Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Infect Immun ; 78(1): 301-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19901067

ABSTRACT

Leishmania (subgenus Viannia) braziliensis is the causative agent of mucocutaneous leishmaniasis (ML) in South America, and ML is characterized by excessive T- and B-cell responses to the parasite. We speculate that the unbalanced production of inflammatory mediators in response to L. braziliensis infection contributes to cell recruitment and disease severity. To test this hypothesis, we first examined the response of peripheral blood mononuclear cells (PBMCs) from healthy volunteers to L. braziliensis infection. We observed that while L. braziliensis infection induced the production of chemokine (C-X-C motif) ligand 10 (CXCL10) and interleukin-10 (IL-10) in human PBMCs and macrophages (MPhis), enhanced expression of CXCL10 and its receptor, chemokine CXC receptor (CXCR3), was predominantly detected in CD14(+) monocytes. The chemoattractant factors secreted by L. braziliensis-infected cells were highly efficient in recruiting uninfected PBMCs (predominantly CD14(+) cells) through Transwell membranes. Serum samples from American tegumentary leishmaniasis (ATL) patients (especially the ML cases) had significantly higher levels of CXCL10, CCL4, and soluble tumor necrosis factor (TNF) receptor II (sTNFRII) than did those of control subjects. Our results suggest that, following L. braziliensis infection, the production of multiple inflammatory mediators by the host may contribute to disease severity by increasing cellular recruitment.


Subject(s)
Chemokine CXCL10/metabolism , Leishmania braziliensis/physiology , Leishmaniasis, Cutaneous/immunology , Monocytes/metabolism , Monocytes/parasitology , Animals , Cells, Cultured , Chemokine CXCL10/genetics , Gene Expression Regulation/immunology , Humans , Leishmaniasis, Cutaneous/metabolism , Receptors, CXCR3/genetics , Receptors, CXCR3/metabolism
2.
Infect Immun ; 77(7): 2948-56, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19364834

ABSTRACT

We have previously reported that Leishmania braziliensis infection can activate murine dendritic cells (DCs) and upregulate signaling pathways that are essential for the initiation of innate immunity. However, it remains unclear whether Toll-like receptors (TLRs) are involved in L. braziliensis-mediated DC activation. To address this issue, we generated bone marrow-derived DCs from MyD88(-/-) and TLR2(-/-) mice and examined their responsiveness to parasite infection. While wild-type DCs were efficiently activated to produce cytokines and prime naïve CD4(+) T cells, L. braziliensis-infected MyD88(-/-) DCs exhibited less activation and decreased production of interleukin-12 (IL-12) p40. Furthermore, MyD88(-/-) mice were more susceptible to infection in that they developed larger and prolonged lesions compared to those in control mice. In sharp contrast, the lack of TLR2 resulted in an enhanced DC activation and increased IL-12 p40 production after infection. As such, L. braziliensis-infected TLR2(-/-) DCs were more competent in priming naïve CD4(+) T cells in vitro than were their controls, findings which correlated with an increased gamma interferon production in vivo and enhanced resistance to infection. Our results suggest that while MyD88 is indispensable for the generation of protective immunity to L. braziliensis, TLR2 seems to have a regulatory role during infection.


Subject(s)
Dendritic Cells/immunology , Leishmania braziliensis/immunology , Leishmaniasis, Cutaneous/immunology , Myeloid Differentiation Factor 88/immunology , Toll-Like Receptor 2/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , Cytokines/metabolism , Leishmaniasis, Cutaneous/pathology , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/deficiency , Severity of Illness Index , Toll-Like Receptor 2/deficiency
SELECTION OF CITATIONS
SEARCH DETAIL